Even though there was a significant trend in the accumulation of CAR-T cells in syngeneic gliomas with the addition of FUS, corroborating previously highlighted data in xenografts, the path to therapeutic benefit in light of mechanisms such as myeloid immunosuppression and T-cell exhaustion remains complex.
← all excerpts
Focused ultrasound for enhancing cell-based immunotherapies in neuro-oncology.
1
—
—